Saturday 17 October 2026
Export MIRA’s income statement to Excel — free account
MIRA Pharmaceuticals, Inc.
MIRA Healthcare Drug Manufacturers General
In the quarter to June 2026, EPS grew 66.7% and free cash flow fell 50.8%, each against the same quarter a year earlier.
0.63
0.03
−4.55%
Follow MIRA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
200.19 | 82.13 | 15.75 | 90.56 |
+8 more quarters Free account |
Net Debt/EBITDA |
7.02 | 8.52 | 1.89 | 5.72 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.00 | 1.04 | 0.19 | 0.05 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.03) | (0.03) | (0.05) | (0.06) | |
Cash per Share |
0.19 | 0.22 | 0.47 | 0.39 | |
Shareholders Equity per Share |
0.19 | 0.22 | 0.44 | 0.39 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.19 | 0.22 | 0.44 | 0.39 | |
Free Cash Flow |
(1.21) | (1.20) | (1.14) | (1.10) | |
Working Capital |
8.13 | 9.31 | 10.36 | 7.51 | |
Net Current Asset Value |
8.13 | 9.31 | 10.36 | 7.51 | |
| Other line items | |||||
Quick Ratio |
198.86 | 81.94 | 15.71 | 89.82 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.03) | (0.03) | (0.05) | (0.06) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
0.17 | 0.07 | 0.43 | 0.39 | |
Average Assets |
4.54 | 5.43 | 7.01 | 5.95 | |
Average Common Equity |
4.37 | 5.32 | 6.30 | 5.56 |
Columns are period end dates